Search results
Earnings call: The Oncology Institute sees revenue climb, plans growth By Investing.com
Investing.com· 2 days agoDespite facing challenges including margin compression and a cyberattack, TOI signed seven new...
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through...
Morningstar· 7 days agoLemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only ...
Earnings call: Aytu BioPharma sees revenue growth, shifts focus to ADHD By Investing.com
Investing.com· 5 days agoAytu BioPharma (ticker: AYTU), a specialty pharmaceutical company, has reported a significant...
The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 6 days agoTOI reports a robust revenue increase and strategic expansions, counterbalanced by margin pressures and operational losses in the first quarter of 2024.
How to become a pharmacy tech | Napa Valley Register
Napa Valley Register· 1 day agoEver pictured yourself behind a pharmacy counter playing an important role in healthcare? Maybe you’re nervous about the daunting “how” and “where to start” questions. Because
Q1 2024 scPharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoTo that end, earlier this month, we submitted a supplemental new drug application with the FDA for the CKD indication. At this point, I'll turn the call over to our Senior ...
New York State officials being lobbied to embrace Opvee, a Narcan alternative
Newsday· 2 days agoA newcomer in the fight against opioid overdoses is lobbying to receive the state’s approval to be...
President Says Inflation Moving in the Right Direction, But We Don't See It Yet
Shore NewsNetwork· 9 hours agoThe cost of eggs, meat, olive oil, gasoline, electricity, natural gas, health insurance, car...
Q3 2024 Aytu Biopharma Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoWe're solving this issue and our results speak to that. And as we look at prescription trends in April and into May, we're seeing growth in Rxs for the ADHD brands. In fact ...
Earnings call: Harrow Inc. reports robust revenue growth in Q1 2024 By Investing.com
Investing.com· 6 days agoHarrow, Inc. (ticker not provided), a prominent player in the ophthalmic pharmaceuticals industry,...
